Amrutanjan Health Care is a 130-year-old Ayurvedic FMCG company selling OTC pain relief (Amrutanjan balm), women’s hygiene (Comfy pads), and health beverages (ElectroPlus). Key growth drivers include Rs 123 crore capex for a dedicated Comfy plant (FY25) to boost EBIT margins by 200 bps to 13-14%, new product launches like GP Paracetamol (FY25) and antifungal spray Stop Pain, and distribution expansion targeting 1 lakh new chemist outlets in 2-3 years. Quick commerce revenue is growing at 200% MoM, while ElectroPlus benefits from global warming-driven rehydration demand. The Rs 1,000 crore revenue target by FY28 hinges on pain category recovery, Comfy’s margin normalization, and successful execution of digitization and SAP integration. Key execution risk: margin compression from pricing pressures in the OTC pain segment.
companyname: Amrutanjan Health Care Limited ticker: AMRUTANJAN sector: Healthcare / FMCG (Ayurvedic pharmaceuticals, women's hygiene, beverages) Amrutanjan Health Care is one of the oldest FMCG companies in India, incorporated in 1936 but tracing its founding product back to 1893. It manufactures and sells pain relief products (balms, roll-ons, sprays), sanitary napkins, and rehydration drinks. The company operates three manufacturing units, works with 1,656 distributors, and reaches 1.11 milli...
Read the full report →capex, margin expansion, new product segment
Rs 1000 crores revenue target by FY28
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Amrutanjan Health Care Limited and 4,900+ companies.
5-day free pass. No card required.